Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Taranabant CB1 Receptor Inverse Agonist for Management of Obe

Initial weight loss interventions, based on BMI and waist circumference, recommended in the National Institute for Clinical Excellence (NICE) guidelines.



  • Percentage of men and women classified as obese

Go Top